Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial.
Invest New Drugs
; 40(2): 330-339, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34633576
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Mitoxantrone
Type of study:
Clinical_trials
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Invest New Drugs
Year:
2022
Type:
Article
Affiliation country:
China